VINCENNES — Good Samaritan will close its hospice program effective Dec. 31, 2025, announced in a press release Friday morning.

The decision, made by the hospital’s Executive Team and Board of Governors, followed “a careful evaluation of health care trends and reflects Good Samaritan’s commitment to responsible stewardship and long-term sustainability.”

“Since its beginning, our hospice team has provided extraordinary, compassionate care to patients and families across our region,” said Rob McLin, CEO of Good Samaritan, in the press release. “We hold deep respect for that legacy and are committed to supporting our patients, families, and hospice team throughout this transition.”

In response to the changes with the delivery of hospice care and how it has evolved — with services increasingly provided by organizations dedicated exclusively to end-of-life care — Good Samaritan said it is “focusing on meeting community needs through its core hospital and outpatient service offerings, while ensuring continuity of care for hospice patients.”

Good Samaritan also stated in the press release that it will continue to provide palliative care services, “which have long operated in conjunction with hospice,” and remains a required component of the hospital’s Commission on Cancer accreditation.

“We have a responsibility to make decisions that protect the future of our community-driven hospital,” said McLin in the press release. “By making this transition proactively, while we are in a position of stability, we can provide thoughtful support to our patients, families, and team through the change.”

As part of the transition, all current hospice patients will receive a letter with more details about the transition and the resources available to them, according to the press release.

“Good Samaritan is working closely with regional hospice providers and is actively exploring multiple partnership strategies to ensure hospice care throughout the communities we serve is provided seamlessly.”
Copyright ©2025 Vincennes Sun Commercial